|
 |
||
      |
|
|
» Apply for a Grant
- FAQs - Young Investigator - Independent Investigator - Distinguished Investigator - Staglin Award » Grantee List - Young Investigators - Independent Investigators - Distinguished Investigators - Staglin Awards
» Prizes
- Lieber Prize - Falcone Prize - Ruane Prize - Goldman-Rakic Prize - Freedman Award - Klerman Award » For Grantees - Young Investigator Fact Sheet - Independent Investigator Fact Sheet - Distinguished Investigator Fact Sheet - Staglin Award Fact Sheet 
|
 Project Summary  Kent C. Harris, Ph.D. (Young Investigator 2003) of Huntington Medical Research Institute, purports that it is highly probable that the status of neuronal metabolism is closely related to the progression, arrest and reversal of schizophrenia. Dr. Harris will investigate the hypothesis that a neurochemical, N-acetylaspartate may be an effective therapy for modifying dopamine neurotransmission. Using Magnetic Resonance Spectroscopy (MRS) studies to determine N-acetylaspartate synthesis rates, Dr. Harris will show that such therapy may improve neuronal function and prevent further neuronal injury or loss. Program Area: SCHIZOPHRENIA/PSYCHOTIC DISORDERS\Schizophrenia |
Announcements
NARSAD Award Winners
 Colleen Ann McClung, Ph.D., UT Southwestern Medical Center at Dallas, 2005 & 2007 Young Investigator Latest News from NARSAD
|
